The federal government recently forfeited $13.3 million in proceeds derived from two online poker sites for being in violation of the Unlawful Internet Gambling Enforcement Act (“UIGEA”). According to the […]
On September 1, 2010, the Financial Crimes Enforcement Network (“FinCEN”) of the US Department of the Treasury issued a guidance for financial institutions on Suspicious Activity Reports (“SAR”) involving Informal […]
Pharmawire by Kirsty Barnes 2010-08-24 Intelligence Details Johnson & Johnson (NYSE:JNJ) may face future regulatory action if the result of an internal investigation over its well-publicized good manufacturing practice (GMP) […]
Several of the largest telecommunications companies in the United States including AT&T, Verizon, and Nokia are urging the US government to ease regulations which currently prevent them from operating in Cuba. The regulations stem from the 47 year old trade embargo the US has enforced against Cuba due to the oppressive Castro regime.
NeoStem, Inc. (“NeoStem”) recently announced the appointment of Thomas Einhorn, M.D., Chairman of Orthopaedic Surgery at Boston University to its Medical Advisory Board. NeoStem is an international biopharmaceutical company that is engaged in the development of stem cell-based therapies and building a network of adult stem cell collection centers in the United States and China that allow people to donate and store their own stem cells for their personal use in the event of a future medical need.
On August 20, 2010, U.S. District Court Judge Julie Robinson for the District of Kansas granted the United States Department of Justice’s motion to dismiss the charges against former Westar executives David Wittig and Douglas Lake. The charges were dismissed without prejudice, meaning they could be filed again.
The FDA has begun the process of establishing regulations to implement recent federal law that mandates calorie information be posted at many chain restaurants and vending machines throughout the United […]
On August 19, 2010, the Office of Foreign Assets Control, (“OFAC”), of the U.S. Department of the Treasury announced that it has reached a settlement with Banco Colpatria, S.A., (“Colpatria”), for alleged violations of OFAC’s Narcotics Trafficking Sanctions Regulations. The alleged violations stem from activities of Colpatria’s Miami Agency which discontinued operations in 2007. OFAC is a part of the U.S. Department of the Treasury and administers and enforces economic sanctions against targeted foreign countries, regimes, terrorists, international narcotics traffickers, among others.
On August 18, 2010, the United States Department of Treasury Office of Foreign Assets Control announced that it has reached a settlement with Barclays Bank PLC to settle allegations of violations of multiple sanctions programs relating to transactions Barclays conducted with customers from Cuba, Sudan, Burma, and Iran. Barclays Bank is the United Kingdom’s second largest bank earning $14.8 billion in net income last year. The Office of Foreign Assets Control (“OFAC”) administers and enforces economic sanctions against targeted foreign countries, regimes, terrorists, international narcotics traffickers, among others.
The U.S. Food and Drug Administration (FDA) reported more than 1,742 prescription and over-the-counter (OTC) drug recalls in 2009. That number is a huge increase from the 426 recalls reported in 2008 and the 391 recalls reported in 2007. With the spike in the number of drug product recalls, product and manufacturing quality is being called into question in the media and in the public.
